Nasdaq:US$16.90 (-0.82) | HKEX:HK$27.20 (-0.95) | AIM:£2.52 (-0.11)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 29 Jul 2009

Patient Enrolment Completed Ahead of Schedule for the Global Phase IIb Ulcerative Colitis Trial of HMPL-004

1 items
a090729